Transplant Diagnostics Market in North America to witness an Incremental Growth of over $190 Million
Arizton’s recent market research report on the Transplant Diagnostics Market - Global Outlook and Forecast 2020-2025 provides comprehensive industry analysis, trend forecasts, and competitive analysis. The study includes insights by product (instruments & software and consumables & test kits), application (diagnostic and research), technology (molecular and non-molecular), transplantation type (solid organ and soft tissue), end-users (standard reference laboratories, hospitals & transplant centers, and research & academic Institutes), and geography (Europe, North America, APAC, Latin America, and MEA).
The global transplant diagnostic market is expected to grow at a CAGR of over 5% during the period 2019−2025.
Request for your free sample now!
The high demand for molecular diagnostic tests and the availability of technologically advanced devices are contributing to the high demand of transplant diagnostics devices. The increasing demand for innovative transplant diagnostics instruments/analyzers and software for fast, safe, and accurate diagnostic results related to organ, cell, and tissue transplantations among healthcare professionals (HCPs) will drive the market during the forecast period.
The global market is segmented into products, technology, transplantation type, end-users, and geography.
Availability of Innovative Molecular Testing Techniques boosting Reagents & Consumables Segment Growth
The reagents & consumables segment is growing at a faster rate than instruments & software product segment owing to their recurring purchase by end-users for performing a wide array of molecular and non-molecular transplant diagnostic tests. Technological advancements with NGS and PCR-based molecular testing techniques are influencing the adoption of transplant diagnostics molecular assays, test kits, and reagents. Also, modern test kits are capable to offer test results quickly. For instance, Immucor’s LIFECODES HLA Typing Kits utilizes SSO methodology to identify HLA alleles in PCR-amplified sample, which gives results within two hours. Also, another key player QIAGEN offers Artus HSV-1/2 PCR Kits CE, a ready-to-use molecular detection kit for real-time PCR, which can detect low numbers of HSV-1/2 DNA with highest sensitivity.
Diagnostic Applications Segment to grow at a CAGR of over 6%
The diagnostic segment is expected to witness an incremental growth of over $370 million during the forecast period. The availability of high-quality diagnostic tests is important for transplant patients at each stage of the process. These tests help to assess donor-recipient compatibility, prevent and/or control infections, and prescribe appropriate immunosuppressive therapy. Further, transplant patient care is complicated as patients are at risk for a wide range of infections, thereby increasing the applications of advanced diagnostic tests and devices. Also, in the US, the prevalence of HSV-1 infections, the classic oro-labial herpes virus in early childhood, is approximately 44% in 12–19-year-old population and approximately 80% in 60 years old people. Similarly, HSV-2 affects about 26% of people aged between 40 and 49 years in the US. Such rising risks of developing various infections post-transplantation and the growing need to minimize such life-threatening infections is encouraging various healthcare providers to use a wide array of diagnostic tests for effective monitoring of transplanted patients.
US to dominate Transplant Diagnostic Market
North America accounts a market share of 42% of the global transplant diagnostics market. The region is expected to witness an incremental growth of over $190 million during the forecast period. The US is the major revenue contributor to the North America transplant diagnostics market. The country holds the highest market value due to better healthcare accessibility. Also, the country is witnessing significant increase in the number of solid organ and tissue transplantations. For instance, in 2018 approximately 38,222 solid organ transplantations were performed in the US. In addition, about 21,444 bone marrow transplantations were recorded in 2017 in the country. Moreover, approximately more than 145 million people over the age of 18 had registered as organ donors in 2018, which represented more than half of the total US adult population.
Request for your free sample now!
Thermo Fisher Scientific, Hoffmann-La Roche, bioMérieux, Bio-Rad Laboratories, QIAGEN, and Immucor are key vendors in the global transplant diagnostic market.
The complete overview of the latest market research report on the global transplant diagnostic market by Arizton is now available.
The report offers a detailed study of major trends, drivers, challenges and provides market sizing and forecast for major geographical regions and key countries.
About Arizton
Arizton – Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Mail: enquiry@arizton.com
Call: +1-312-235-2040
+1 302 469 0707